Suggested Formulations for Mometasone Furoate Combinations

被引：0
作者：
Melhorn, Stefanie [1 ]
Staubach, Petra [2 ]
机构：
[1] Avoxa Mediengrp Deutsch Apotheker GmbH, Deutsch Arzneimittel Codex Neues Rezeptur Formula, Carl Mannich Str 26, D-65760 Eschborn, Germany
[2] Univ Med Mainz, Hautklin & Poliklin, Mainz, Germany
来源：
HAUTARZT | 2019年 / 70卷 / 07期
关键词：
D O I：
10.1007/s00105-019-4439-z
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：550 / 553
页数：4
相关论文
共 50 条
  • [1] Suggested Formulations for Mometasone Furoate
    Melhorn, Stefanie
    Staubach, Petra
    HAUTARZT, 2019, 70 (05): : 392 - 394
  • [2] Rezepturvorschläge zu Mometasonfuroat-KombinationenSuggested formulations for mometasone furoate combinations
    Stefanie Melhorn
    Petra Staubach
    Der Hautarzt, 2019, 70 : 550 - 554
  • [3] Rezepturvorschläge zu MometasonfuroatSuggested formulations for mometasone furoate
    Stefanie Melhorn
    Petra Staubach
    Der Hautarzt, 2019, 70 : 392 - 394
  • [4] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 70
  • [5] Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate
    Fardon, TC
    Lee, DKC
    Haggart, K
    McFarlane, LC
    Lipworth, BJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (09) : 960 - 966
  • [6] Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel
    Greive, Kerryn A.
    Barnes, Tanya M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 (02) : E39 - E45
  • [7] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma (vol 70, 102068, 2021)
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 73
  • [8] Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate
    Weinstein, Cindy L. J.
    Ryan, Nicholas
    Shekar, Tulin
    Gates, Davis
    Lane, Stephen J.
    Agache, Ioana
    Nathan, Robert A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (04) : 1395 - 1402
  • [9] EFFICACY AND SAFETY OF MOMETASONE FUROATE/FORMOTEROL COMPARED WITH MOMETASONE FUROATE IN CHILDREN WITH PERSISTENT ASTHMA
    Weinstein, C.
    Gates, D.
    Zhang, X.
    Jain, N.
    Varnell, T.
    Mok, W.
    Vermeulen, J.
    Amar, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S35 - S35
  • [10] Topical Mometasone Furoate for Phimosis
    Khope, Sanjay
    INDIAN PEDIATRICS, 2010, 47 (03) : 282 - 282
12345